These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


275 related items for PubMed ID: 30098312

  • 21. Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice.
    Nozaki C, Markert A, Zimmer A.
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1388-96. PubMed ID: 25910421
    [Abstract] [Full Text] [Related]

  • 22. Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety.
    Danandeh A, Vozella V, Lim J, Oveisi F, Ramirez GL, Mears D, Wynn G, Piomelli D.
    Psychopharmacology (Berl); 2018 Nov; 235(11):3211-3221. PubMed ID: 30251159
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Inhibition of microglial fatty acid amide hydrolase modulates LPS stimulated release of inflammatory mediators.
    Tham CS, Whitaker J, Luo L, Webb M.
    FEBS Lett; 2007 Jun 26; 581(16):2899-904. PubMed ID: 17543306
    [Abstract] [Full Text] [Related]

  • 28. Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells.
    Winkler K, Ramer R, Dithmer S, Ivanov I, Merkord J, Hinz B.
    Oncotarget; 2016 Mar 22; 7(12):15047-64. PubMed ID: 26930716
    [Abstract] [Full Text] [Related]

  • 29. Beneficial Changes in Rat Vascular Endocannabinoid System in Primary Hypertension and under Treatment with Chronic Inhibition of Fatty Acid Amide Hydrolase by URB597.
    Baranowska-Kuczko M, Kozłowska H, Kloza M, Harasim-Symbor E, Biernacki M, Kasacka I, Malinowska B.
    Int J Mol Sci; 2021 May 02; 22(9):. PubMed ID: 34063297
    [Abstract] [Full Text] [Related]

  • 30. N-arachidonoyl-serotonin, a dual FAAH and TRPV1 blocker, inhibits the retrieval of contextual fear memory: Role of the cannabinoid CB1 receptor in the dorsal hippocampus.
    Gobira PH, Lima IV, Batista LA, de Oliveira AC, Resstel LB, Wotjak CT, Aguiar DC, Moreira FA.
    J Psychopharmacol; 2017 Jun 02; 31(6):750-756. PubMed ID: 28583049
    [Abstract] [Full Text] [Related]

  • 31. Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson's disease.
    Celorrio M, Fernández-Suárez D, Rojo-Bustamante E, Echeverry-Alzate V, Ramírez MJ, Hillard CJ, López-Moreno JA, Maldonado R, Oyarzábal J, Franco R, Aymerich MS.
    Brain Behav Immun; 2016 Oct 02; 57():94-105. PubMed ID: 27318096
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of endocannabinoid-degrading enzyme fatty acid amide hydrolase increases atherosclerotic plaque vulnerability in mice.
    Hoyer FF, Khoury M, Slomka H, Kebschull M, Lerner R, Lutz B, Schott H, Lütjohann D, Wojtalla A, Becker A, Zimmer A, Nickenig G.
    J Mol Cell Cardiol; 2014 Jan 02; 66():126-32. PubMed ID: 24286707
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of FAAH confers increased stem cell migration via PPARα.
    Wollank Y, Ramer R, Ivanov I, Salamon A, Peters K, Hinz B.
    J Lipid Res; 2015 Oct 02; 56(10):1947-60. PubMed ID: 26263913
    [Abstract] [Full Text] [Related]

  • 34. Inhibition of fatty-acid amide hydrolyse (FAAH) exerts cognitive improvements in male but not female rats.
    Hlavacova N, Chmelova M, Danevova V, Csanova A, Jezova D.
    Endocr Regul; 2015 Jul 02; 49(3):131-6. PubMed ID: 26238495
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA, Kaiser N, Monory K, Lutz B.
    Neuropharmacology; 2008 Jan 02; 54(1):141-50. PubMed ID: 17709120
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.